Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

Inhibitors Of Virion Release

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

Size and Structure of Viral Genomes

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.

Science immunology·2021

Same author

SnapShot: SARS-CoV-2 antibodies.

Cell host & microbe·2021

Same author

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.

Cell·2021

Same author

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants.

Human vaccines & immunotherapeutics·2021

Same author

Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.

PLoS pathogens·2021

Same author

Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.

Cell·2021

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

Mechanisms by which HIV envelope minimizes immunogenicity.

Haixiang Jiang¹, Garren Hester, Larry Liao

¹Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.

Immunologic Research

|December 17, 2010

Summary

HIV-1 envelope protein gp140 vaccines show weak immunogenicity due to poor complement binding and rapid degradation. These factors limit the development of a strong, long-lasting immune response against HIV-1.

More Related Videos

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers

Published on: March 8, 2012

Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding

Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding

Published on: September 15, 2010

Related Experiment Videos

Last Updated: Jun 6, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers

Published on: March 8, 2012

Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding

Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding

Published on: September 15, 2010

Area of Science:

Immunology
Virology
Vaccine Development

Background:

Traditional vaccines using viral envelope antigens often induce robust immunity, but this has not been achieved with Human Immunodeficiency Virus type 1 (HIV-1) envelope vaccines.
Despite extensive research over two decades, HIV-1 vaccines have yielded weak or absent protection, necessitating investigation into the underlying mechanisms.

Purpose of the Study:

To systematically investigate the characteristics of HIV-1 envelope glycoprotein 140 (gp140), a key protein in HIV infectivity.
To identify specific properties of HIV-1 gp140 that may contribute to its reduced immunogenicity.

Main Methods:

Systematic laboratory investigation of HIV-1 envelope gp140 characteristics.
Analysis of complement binding properties of HIV-1 gp140.
Assessment of the stability and degradation profile of HIV-1 gp140 following injection.

Main Results:

HIV-1 envelope gp140 demonstrates poor complement binding, which is crucial for increasing immunogenicity and directing the type of immune response.
Absence of proper complement binding leads to reduced, short-lived antibody responses with diminished memory cell formation, alongside increased antibody affinity maturation.
HIV-1 gp140 exhibits significant instability upon injection, leading to rapid clearance and degradation into peptides, limiting its effective presentation to the immune system.

Conclusions:

The inability of HIV-1 gp140 to bind complement and its inherent instability are critical factors contributing to the poor immunogenicity observed in HIV-1 vaccines.
These properties likely hinder the initiation of effective and durable immune responses required for protection against HIV-1 infection.